PIONEER AF-PCI: Rivaroxaban + P2Y12 Inhibitor clopidogrel ~94% or Rivaroxaban + DAPT vs. Warfarin + DAPT in Patients with Atrial
Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI ( PIONEER): Three May End Up Being a Crowd - Samuel A. Berkman, 2018
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study Design | Radcliffe Cardiology
![PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF](https://d3i71xaburhd42.cloudfront.net/4107965fd29bd24ad0a28eea66938425b733e805/4-TableI-1.png "PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF")
PDF] Evaluation of the safety and efficacy of an edoxaban‐based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST‐AF
PIONEER AF-PCI Trial: Inclusion and Main Exclusion Criteria and Study... | Download Scientific Diagram
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology
New Perspectives in AF and PCI: Implications for the Practicing Physician. - ppt download
![臨床藥學] PIONEER AF-PCI：心房顫動合併冠心症接受心導管治療，Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS](https://4.bp.blogspot.com/-ki6zrPeBWxI/WCpzKF9yAbI/AAAAAAABXc4/evvkGYfo10QidY4RLi4YXaODj2ZOT5-hgCLcB/s1600/NEJS%2B20160905.png "臨床藥學] PIONEER AF-PCI：心房顫動合併冠心症接受心導管治療，Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS")
臨床藥學] PIONEER AF-PCI：心房顫動合併冠心症接受心導管治療，Rivaroxaban降低心導管後出血風險(Bleeding in Patients with AF Undergoing PCI) - NEJS
JCM | Free Full-Text | Antithrombotic Strategies in Patients with Atrial Fibrillation Following Percutaneous Coronary Intervention: A Systemic Review and Network Meta-Analysis of Randomized Controlled Trials
Davide Capodanno on Twitter: "#PIONEER, #REDUAL, #AUGUSTUS, and #ENTRUST in a nutshell: The Fab Four in #AF #PCI https://t.co/ve7enVHwM7" / Twitter
Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI | Challenges in Cardiology
Changes of antithrombotic prescription in atrial brillation patients with acute coronary syndrome or percutaneous coronary inter
The PIONEER AF-PCI study: its implications for everyday practice in the UK - The British Journal of Cardiology
Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis | Open Heart
Adobe AudienceManager
Frontiers | Antithrombotic Management for Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention or With Acute Coronary Syndrome: An Evidence-Based Update
Patients with AF undergoing PCI | Thrombosis Adviser
How will PIONEER-AF change our practice? - ppt download
Advances in Coronary Artery Disease: Moving Beyond Antiplatelet Therapy (Transcript)
Anticoagulation in patients with non-valvular AF undergoing PCI: clinical evidence from PIONEER AF-PCI - The British Journal of Cardiology
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art Review - ScienceDirect
